Extract

Review Article

Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials

The most clinically relevant data from breast cancer treatment clinical trials are summarized. Biological predictive markers, and the safety and efficacy of common antiangiogenic therapies are also discussed.

Fakhrejahani, E. and Toi, M. Jpn J Clin Oncol 2014 44:3 197–207

Original Articles

Gastrointestinal Medicine

Effect of the Weekly Administration of Liposome–Paclitaxel Combined with S-1 on Advanced Gastric Cancer

No standard regime is globally accepted in advanced gastric cancer. This study shows the combined regime of weekly liposome–paclitaxel plus S-1 is effective and tolerable in advanced gastric cancer.

Chen, L., Chen, Q., Zhuang, Z., et al. Jpn J Clin Oncol 2014 44:3 208–213

Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients

This large post-marketing survey confirms the clinical safety and effectiveness of panitumumab. The benefit/risk balance for panitumumab in Japanese patients with unresectable colorectal cancer remains favorable.

You do not currently have access to this article.